Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Hypoxia‐inducible factor (HIF) stabilisers vs erythropoiesis‐stimulating agent (ESA)

Nonfatal myocardial infarction Median · people with CKD (including HD and PD)

Hypoxia‐inducible factor (HIF) stabilisers showed no clear difference in nonfatal myocardial infarction Median compared with erythropoiesis‐stimulating agent (ESA) (low certainty).

1 finding from 1 review

Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease 2022 · Cochrane Headline outcomes only
RR 0.91 [0.76, 1.1]
7 studies · 7765 participants
Low

Hypoxia‐inducible factor (HIF) stabilisers vs placebo

Nonfatal myocardial infarction Median · people with CKD (including HD and PD)

It is very uncertain whether hypoxia‐inducible factor (HIF) stabilisers changes nonfatal myocardial infarction Median compared with placebo (very low certainty).

1 finding from 1 review

Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease 2022 · Cochrane Headline outcomes only
RR 1.29 [0.31, 5.36]
3 studies · 822 participants
Very low